3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER_GOV
1
OTHER
1
NIH
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Lung Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Wilms Tumor
2
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma, Ewing
2
Sarcoma
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Adenocarcinoma of Lung
2
Adenocarcinoma Of Esophagus
2
Vaginal Neoplasms
1
Urethral Neoplasms
1
Testicular Neoplasms
1
Teratoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Radiation Injuries
1
Radiation Fibrosis Syndrome
1
Prostatic Neoplasms
1
Postoperative Complications
1
Ovarian Germ Cell Cancer
1
Osteosarcoma
1
Interventions
Docetaxel
3
regorafenib
2
Doxorubicin
2
trifluridine tipiracil drug combination
1
pegfilgrastim
1
enzalutamide
1
darolutamide
1
bicalutamide
1
apalutamide
1
abiraterone
1
Triptorelin Pamoate
1
Trifluridine
1
Surgical Procedures, Operative
1
Pancreaticoduodenectomy
1
Paclitaxel
1
Nivolumab
1
Irinotecan
1
Cyclophosphamide
1
Cisplatin
1
CP protocol
1
Bevacizumab
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Adenocarcinoma
×
Surgical Procedures, Operative
×
Clear all
NCT01419002
2015-07-29
Net-Pac
CHIR-Net
Phase 3
Terminated
5 enrolled